Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 235

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

Open access
on behalf of the NCRI Haemato-oncology CSG, Shah, V, Sherborne, A L, Walker, B A, Johnson, D C, Boyle, E M, Ellis, S, Begum, D B, Proszek, P Z, Jones, J R, Pawlyn, C, Savola, S, Jenner, M W, Drayson, M T, Owen, R G, Houlston, R S, Cairns, D A, Gregory, W M, Cook, G, Davies, F E, Jackson, G H, Morgan, G J, Kaiser, M F · 2018 · Leukemia

Abstract

Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent genetic aberrations is required as outcomes are variable despite apparent similar staging. We assayed copy number alterations (CNA) and translocations in 1036 patients from the NCRI Myeloma XI trial and linked these to overall survival (OS) and progression-free survival. Through a meta-anlysis of these data with data from MRC Myeloma IX trial, totalling 1905 newly diagnosed MM patients (NDMM), we confirm the association of t(4;14), t(14;16), t(14;20), del(17p) and gain(1q21) with poor prognosis with hazard ratios (HRs) for OS of 1.60 ( P =4.77 × 10 −7 ), 1.74 ( P =0.0005), 1.90 ( P =0.0089), 2.10 ( P =8.86 × 10 −14 ) and 1.68 ( P =2.18 × 10 −14 ), respectively. Patients with ‘double-hit’ defined by co-occurrence of at least two adverse lesions have an especially poor prognosis with HRs for OS of 2.67 ( P =8.13 × 10 −27 ) for all patients and 3.19 ( P =1.23 × 10 −18 ) for intensively treated patients. Using comprehensive CNA and translocation profiling in Myeloma XI we also demonstrate a strong association between t(4;14) and BIRC2/BIRC3 deletion ( P =8.7 × 10 −15 ), including homozygous deletion. Finally, we define distinct sub-groups of hyperdiploid MM, with either gain(1q21) and CCND2 overexpression ( P <0.0001) or gain(11q25) and CCND1 overexpression ( P <0.0001). Profiling multiple genetic lesions can identify MM patients likely to relapse early allowing stratification of treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2017.179

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 235

Metadata

Authors
CSG, O. B. O. T. N. H.-O., Shah, V, Sherborne, A. L., Walker, B. A., Johnson, D. C., Boyle, E. M., Ellis, S., Begum, D. B., Proszek, P. Z., Jones, J. R., Pawlyn, C., Savola, S., Jenner, M. W., Drayson, M. T., Owen, R. G., Houlston, R. S., Cairns, D. A., Gregory, W. M., Cook, G., Davies, F. E., Jackson, G. H., Morgan, G. J., & Kaiser, M. F.
Venue
Leukemia
Published
2017-06-06
Volume
32
Issue
1
Pages
102-110
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2622796688
Cited by
235
References
8
FWCI
3.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. https://app.cochat.ai/papers/10.1038/leu.2017.179
The paper
CSG, O. B. O. T. N. H.-O., Shah, V, Sherborne, A. L., Walker, B. A., Johnson, D. C., Boyle, E. M., Ellis, S., Begum, D. B., Proszek, P. Z., Jones, J. R., Pawlyn, C., Savola, S., Jenner, M. W., Drayson, M. T., Owen, R. G., Houlston, R. S., Cairns, D. A., Gregory, W. M., Cook, G., . . . Kaiser, M. F. (2018). Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia. https://doi.org/10.1038/leu.2017.179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.